Campaigner briefings – corporate control of medicines

In the UK, billions of pounds are spent on medical research and development from the public purse. But the most lucrative-looking research is often bought up by big companies, which patent new drugs and sell them at extortionate prices. This leaves hundreds of millions of people in the global south unable to access medicines. Even the NHS is struggling to pay for new treatments and has had to ration or turn down drugs because of the high prices being charged by pharmaceutical companies. 

To find out more, please download our campaigner briefings. 

Download File